Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Open Non Comparative Trial to Evaluate Efficacy and Safety of Tegretol® in Diabetes Neuropathy Pain.

NCT01089855 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01089855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01089855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Open Non Comparative Trial to Evaluate Efficacy and Safety of Tegretol® in Diabetes Neuropathy Pain.
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
Not reported
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain